Literature DB >> 15648780

Associations of serum TRAIL concentrations, anthropometric variables, and serum lipid parameters in healthy adults.

Jong Weon Choi1, Jung Soo Song, Soo Hwan Pai.   

Abstract

To investigate the relationships of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), anthropometric variables, and lipid parameters, we measured serum TRAIL concentrations, body mass index (BMI), total body fat (TBF), and serum lipid profiles in 207 healthy adults. There were no significant differences in serum TRAIL concentrations between men and women, nor between elderly persons and middle-aged subjects. However, men with TBF 16.4 kg (75th per centile) exhibited significantly higher serum TRAIL concentrations than those with TBF 11.2 kg (25th per centile) (69.7 +/- 15.1 pg/ml vs 50.2 +/- 14.3 pg/ml, p < 0.05). Serum TRAIL concentration averaged 76.2 +/- 16.1 pg/ml in women with low-density lipoprotein cholesterol (LDL-C) 165 mg/dl (75th per centile), which was significantly above the values (53.1 +/- 12.9 pg/ml, p < 0.05) in those with LDL-C 117 mg/dl (25th per centile), although no differences were observed on the basis of TBF (75th percentile vs 25th percentile). Serum TRAIL concentrations correlated significantlywithTBF (r = 0.31, p < 0.05) and lean body mass (r = -0.26, p <0.05) in men and LDL-C (r = 0.32, p < 0.05) and total cholesterol (r = 0.21, p < 0.05) in women. In conclusion, serum TRAIL concentrations are associated with serum lipid levels and body adiposity in healthy adults, but are unrelated to a subject's age or gender.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15648780

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  21 in total

1.  A cell-based high-throughput screen to identify synergistic TRAIL sensitizers.

Authors:  Nancy Lynn Booth; Thomas J Sayers; Alan D Brooks; Cheryl L Thomas; Kristen Jacobsen; Ekaterina I Goncharova; James B McMahon; Curtis J Henrich
Journal:  Cancer Immunol Immunother       Date:  2008-12-17       Impact factor: 6.968

2.  TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.

Authors:  Jan-Bernd Funcke; Verena Zoller; Muad Abd El Hay; Klaus-Michael Debatin; Martin Wabitsch; Pamela Fischer-Posovszky
Journal:  FASEB J       Date:  2015-04-09       Impact factor: 5.191

3.  TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe ⁻/⁻ mice.

Authors:  B A Di Bartolo; J Chan; M R Bennett; S Cartland; S Bao; B E Tuch; M M Kavurma
Journal:  Diabetologia       Date:  2011-10-01       Impact factor: 10.122

4.  TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.

Authors:  Leila Idrissova; Harmeet Malhi; Nathan W Werneburg; Nathan K LeBrasseur; Steven F Bronk; Christian Fingas; Tamar Tchkonia; Tamar Pirtskhalava; Thomas A White; Michael B Stout; Petra Hirsova; Anuradha Krishnan; Christian Liedtke; Christian Trautwein; Niklas Finnberg; Wafik S El-Deiry; James L Kirkland; Gregory J Gores
Journal:  J Hepatol       Date:  2014-11-28       Impact factor: 25.083

5.  Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C.

Authors:  N Pelli; A Floreani; F Torre; A Delfino; A Baragiotta; P Contini; M Basso; A Picciotto
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 6.  Genetic variants in candidate genes influencing NAFLD progression.

Authors:  Michelino Di Rosa; Lucia Malaguarnera
Journal:  J Mol Med (Berl)       Date:  2011-09-06       Impact factor: 4.599

7.  Genetic variation in APOJ, LPL, and TNFRSF10B affects plasma fatty acid distribution in Alaskan Eskimos.

Authors:  V Saroja Voruganti; Shelley A Cole; Sven O E Ebbesson; Harald H H Göring; Karin Haack; Sandra Laston; Charlotte R Wenger; M Elizabeth Tejero; Richard B Devereux; Richard R Fabsitz; Jean W MacCluer; Jason G Umans; Barbara V Howard; Anthony G Comuzzie
Journal:  Am J Clin Nutr       Date:  2010-04-21       Impact factor: 7.045

8.  Associations of Circulating Protein Levels With Lipid Fractions in the General Population.

Authors:  Sylwia M Figarska; Stefan Gustafsson; Johan Sundström; Johan Ärnlöv; Anders Mälarstig; Sölve Elmståhl; Tove Fall; Lars Lind; Erik Ingelsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

9.  sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease.

Authors:  Xiaohua Yan; Liyun Xu; Jianni Qi; Xiaohong Liang; Chunhong Ma; Chun Guo; Lining Zhang; Wensheng Sun; Jiyun Zhang; Xiaoyi Wei; Lifen Gao
Journal:  Immunogenetics       Date:  2009-07-23       Impact factor: 2.846

10.  An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.

Authors:  A Ari Hakimi; Helena Furberg; Emily C Zabor; Anders Jacobsen; Nikolaus Schultz; Giovanni Ciriello; Nina Mikklineni; Brandon Fiegoli; Philip H Kim; Martin H Voss; Hui Shen; Peter W Laird; Chris Sander; Victor E Reuter; Robert J Motzer; James J Hsieh; Paul Russo
Journal:  J Natl Cancer Inst       Date:  2013-11-27       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.